Analystreport

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) had its price target lowered by analysts at B. Riley from $7.00 to $5.00.

Infinity Pharmaceuticals, Inc.  (INFI) 
Last infinity pharmaceuticals, inc. earnings: 10/30 04:03 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.infi.com/investor-overview